AJAbhijit Jagdale

Abhijit Jagdale

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abhijit Jagdale has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evidence suggesting that deletion of expression of N‐glycolylneuraminic acid (Neu5Gc) in the organ‐source pig is associated with increased antibody‐mediated rejection of kidney transplants in baboons

    by Hayato Iwase, Abhijit Jagdale, Takayuki Yamamoto, Mohamed H. Bikhet, Huy Q. Nguyen, Mohamed Ezzelarab, David Ayares, Douglas J. Anderson, Devin E. Eckhoff, Jeremy B. Foote, et al.

    Pigs deficient in three glycosyltransferase enzymes (triple‐knockout [TKO] pigs) and expressing “protective” human transgenes are likely sources of organs for transplantation into human recipients. Testing of human sera against red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) from TKO pigs has revealed minimal evidence of natural antibody binding. However, unlike humans, baboons exhibit natural antibody binding to TKO pig cells. The xenoantigen specificities of these natural antibodies are postulated to be one or more carbohydrate moieties exposed when N‐glycolylneuraminic acid (Neu5Gc) is deleted. The aim of this study was to compare the survival of renal grafts in baboons from pigs that either expressed Neu5Gc (GTKO pigs;Group1, n = 5) or didnotexpress Neu5Gc (GTKO/CMAHKO [DKO] or TKO pigs;Group2, n = 5). An anti‐CD40mAb‐based immunosuppressive regimen was administered in both groups.Group1kidneys functioned for 90‐260 days (median 237, mean 196 days), with histopathological features of antibody‐mediated rejection in two kidneys.Group2kidneys functioned for 0‐183 days (median 35, mean 57), with all of the grafts exhibiting histologic features of antibody‐mediated rejection. These findings suggest that the absence of expression of Neu5Gc on pig kidneys impacts graft survival in baboon recipients.


  • A perspective on the potential detrimental role of inflammation in pig orthotopic heart xenotransplantation

    by Charles P. Thompson, Abhijit Jagdale, Gregory Walcott, Hayato Iwase, Jeremy B. Foote, Randall Q. Cron, Hidetaka Hara, David C. Cleveland, David K. C. Cooper

    There is a critical shortage of deceased human donor organs for transplantation. The need is perhaps most acute in neonates and infants with life‐threatening congenital heart disease, in whom mechanical support devices are largely unsuccessful. If orthotopic (life‐supporting) heart transplantation (OHTx) were consistently successful in the genetically engineered pig‐to‐nonhuman primate (NHP) model, a clinical trial of bridging with a pig heart in such patients might be justified. However, the results of pig OHTx in NHPs have been mixed and largely poor. We hypothesise that a factor is the detrimental effects of the inflammatory response that is known to develop (a) during any surgical procedure that requires cardiopulmonary bypass, and (b) immediately after an NHP recipient is exposed to a pig xenograft. We suggest that the combination of these two inflammatory responses has a direct detrimental effect on pig heart graft function, but also, and possibly of more importance, on recipient baboon pulmonary function, which further impacts survival of the pig heart graft. In addition, the inflammatory response almost certainly adversely impacts the immune response to the graft. If our hypothesis is correct, the potential steps that could be taken to reduce the inflammatory response or its effects (with varying degrees of efficacy) include (a) white blood cell filtration, (b) complement depletion or inactivation, (c) immunosuppressive therapy, (d) high‐dose corticosteroid therapy, (e) cytokine/chemokine‐targeted therapy, (f) ultrafiltration or CytoSorb hemoperfusion, (g) reduction in the levels of endogenous catecholamines, (h) triiodothyronine therapy and (i) genetic engineering of the organ‐source pig. Prevention of the inflammatory response, or attenuation of its effects, by judicious anti‐inflammatory therapy may contribute not only to early survival of the recipient of a genetically engineered pig OHTx, but also to improved long‐term pig heart graft survival. This would open the possibility of initiating a clinical trial of genetically engineered pig OHTx as a bridge to allotransplantation.